ABOS
Price
$1.00
Change
-$0.02 (-1.96%)
Updated
Jun 2, 03:59 PM (EDT)
Capitalization
61.78M
77 days until earnings call
GLSI
Price
$9.73
Change
-$0.12 (-1.22%)
Updated
Jun 2, 04:15 PM (EDT)
Capitalization
131.68M
70 days until earnings call
Interact to see
Advertisement

ABOS vs GLSI

Header iconABOS vs GLSI Comparison
Open Charts ABOS vs GLSIBanner chart's image
Acumen Pharmaceuticals
Price$1.00
Change-$0.02 (-1.96%)
Volume$100
Capitalization61.78M
Greenwich LifeSciences
Price$9.73
Change-$0.12 (-1.22%)
Volume$100
Capitalization131.68M
ABOS vs GLSI Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. GLSI commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Buy and GLSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 02, 2025
Stock price -- (ABOS: $1.02 vs. GLSI: $9.85)
Brand notoriety: ABOS and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 61% vs. GLSI: 20%
Market capitalization -- ABOS: $61.78M vs. GLSI: $131.68M
ABOS [@Biotechnology] is valued at $61.78M. GLSI’s [@Biotechnology] market capitalization is $131.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABOS and GLSI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 2 TA indicator(s) are bullish while GLSI’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 2 bullish, 3 bearish.
  • GLSI’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, GLSI is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а 0.00% price change this week, while GLSI (@Biotechnology) price change was +0.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.65%. For the same industry, the average monthly price growth was +3.60%, and the average quarterly price growth was +0.29%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($132M) has a higher market cap than ABOS($61.8M). GLSI YTD gains are higher at: -12.289 vs. ABOS (-40.698). GLSI has higher annual earnings (EBITDA): -10.76M vs. ABOS (-77.89M). ABOS has more cash in the bank: 200M vs. GLSI (5.82M). ABOS (0) and GLSI (0) have equivalent revenues.
ABOSGLSIABOS / GLSI
Capitalization61.8M132M47%
EBITDA-77.89M-10.76M724%
Gain YTD-40.698-12.289331%
P/E RatioN/AN/A-
Revenue00-
Total Cash200M5.82M3,435%
Total Debt28.5MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABOSGLSI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
89%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 28 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDTGX85.790.28
+0.33%
Fidelity Advisor Consumer Staples M
POSKX34.010.03
+0.09%
PRIMECAP Odyssey Stock
GMOIX29.780.02
+0.07%
GMO International Equity III
GSLLX21.70N/A
N/A
Goldman Sachs Enhanced U.S. Equity Inv
DHPYX16.87-0.05
-0.30%
Diamond Hill Mid Cap Y

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-2.86%
FHTX - ABOS
50%
Loosely correlated
-5.56%
ATOS - ABOS
50%
Loosely correlated
+2.18%
BEAM - ABOS
49%
Loosely correlated
-3.00%
ABCL - ABOS
49%
Loosely correlated
-0.98%
CRBU - ABOS
48%
Loosely correlated
-8.62%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-0.71%
ABOS - GLSI
42%
Loosely correlated
-2.86%
XBIT - GLSI
40%
Loosely correlated
-0.35%
GBIO - GLSI
39%
Loosely correlated
-2.58%
ACHV - GLSI
38%
Loosely correlated
+7.19%
ATXS - GLSI
38%
Loosely correlated
-3.84%
More